DIOXOMAXX Trademark

Trademark Overview


On Sunday, July 14, 2013, a trademark application was filed for DIOXOMAXX with the United States Patent and Trademark Office. The USPTO has given the DIOXOMAXX trademark a serial number of 86009804. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, January 19, 2025. This trademark is owned by Bezwada Biomedical, LLC. The DIOXOMAXX trademark is filed in the Chemical Products category with the following description:

Absorbable polymers and polymeric additives made in whole or pertinent part from p-dioxaone for use in the manufacture of sutures, staples, and clips
dioxomaxx

General Information


Serial Number86009804
Word MarkDIOXOMAXX
Filing DateSunday, July 14, 2013
Status800 - REGISTERED AND RENEWED
Status DateSunday, January 19, 2025
Registration Number4610977
Registration DateTuesday, September 23, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements


Pseudo MarkDIOXO MAXX; DIOXO MAX
Goods and ServicesAbsorbable polymers and polymeric additives made in whole or pertinent part from p-dioxaone for use in the manufacture of sutures, staples, and clips

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 22, 2013
Primary Code001
First Use Anywhere DateFriday, June 13, 2014
First Use In Commerce DateFriday, June 13, 2014

Trademark Owner History


Party NameBezwada Biomedical, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHillsborough, NJ 08844

Party NameBezwada Biomedical, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHillsborough, NJ 08844

Party NameBezwada Biomedical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHillsborough, NJ 08844

Trademark Events


Event DateEvent Description
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 17, 2013NEW APPLICATION ENTERED
Monday, July 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2013NOTICE OF PSEUDO MARK E-MAILED
Saturday, October 26, 2013ASSIGNED TO EXAMINER
Thursday, October 31, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 14, 2014TEAS STATEMENT OF USE RECEIVED
Monday, July 14, 2014USE AMENDMENT FILED
Tuesday, August 5, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, August 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, August 17, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 19, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 23, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 23, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 20, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 20, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 20, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 16, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, January 19, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, January 19, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, September 23, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 26, 2024TEAS SECTION 8 & 9 RECEIVED
Sunday, January 19, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED